Twentyfive+ years experience in clinical drug development with significant time spent on both the CRO and sponsor sides; a very rounded background with successful experience in program leadership roles (domestic or international trials, portfolio level), regional site monitoring and data coordination. Therapeutic expertise in pain and analgesics, schedule 1-4 drugs, neuromuscular and rare diseases, oncology, cardiovascular, infectious disease, psychiatric disorders (Phase I-IV inclusive). I also feel it's extremely important to celebrate achievements, appreciate fellow colleagues and foster positivity within my study teams. Recent expertise includes:• Psychedelic and cannabinoid trials • Rare Disease trials • Analgesic research with the intent to develop novel alternatives to opiates and the misuse and abuse of prescription pain medictions.• 10 years of global trial management overseeing cross functional teams located in North America, EU, Asia-Pac, LATAM and expanding markets.• NDA prep and submission readiness for new therapies in oncology, rare disease and CNS (FDA, EU, Japan)• Vendor relations/management• Genetic biosampling flow and oversight• Bid defense/liaising with BDSpecial interest in working with smaller, niche companies or start-ups.